Arsanis, Inc. Registration Rights Agreements
7 Contracts & Agreements
- Registration Rights Agreement, dated May 15, 2023, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on May 16, 2023)
- Registration Rights Agreement, dated June 30, 2022, by and among X4 Pharmaceuticals Inc. and the persons party thereto (Filed With SEC on July 1, 2022)
- Registration Rights Agreement, dated March 3, 2022, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 3, 2022)
- Registration Rights Agreement, dated as of January 14, 2022, by and between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on January 14, 2022)
- Registration Rights Agreement, dated November 5, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on November 5, 2021)
- Registration Rights Agreement, dated March 18, 2021, by and among X4 Pharmaceuticals, Inc. and the persons party thereto (Filed With SEC on March 19, 2021)
- Registration Rights Agreement, dated October 14, 2020, by and between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 16, 2020)
